Ateret Raveh

Shaare Zedek Medical Center

Author Statistics

Papers

Citation

H-Index

i-10 index

Research Trends

Author Order

Document Type

Co-Authors

Irina Schorrs

Shaare Zedek Medical Center

Cathy Hammerman

Shaare Zedek Medical Center

Cai‐Xia Yang

Yangtze University

Soo Heon Kwak

Seoul National University

Javier Naranjo

Hospital Universitario Puerta del Mar

Shimon Shteingart

Jerusalem College of Technology

Y Kim

National University College

Tomer Adar

Hadassah Medical Center

Nereida Fernández Fernández

Servicio Gallego de Salud

Ariella Bar‐Gil Shitrit

Shaare Zedek Medical Center

Cooperative Institutions

Shaare Zedek Medical Center

Instituto de Salud Carlos III

Hospital General Universitario de Alicante Doctor Balmis

Complejo Hospitalario de Salamanca

Keimyung University

Universitat de Miguel Hernández d'Elx

Hebrew University of Jerusalem

Instituto de investigación sanitaria y biomédica de Alicante

Catholic University of Daegu

Hospital General Universitario de Elche

Author Statistics

Papers

Citation

H-Index

i-10 index

Research Field

P137. The oxido-reductases enzymes (TDO2 and SOD2) in colonic mucosa are markers associated with histological activity and clinical course in ulcerative colitis

Journal of Crohn s and Colitis (2016)

Hagai Schweistein Tomer Adar Shimon Shteingart Ateret Raveh Silviu Grisaru

The results provide evidence for the assumptions of the CSM and suggest the importance of addressing illness perceptions and the coping strategy 'decreasing activity' in quality health care for IBD.

SOD2

10.1093/ecco-jcc/jjw019.256

Cite

Citations (0)

SMOFlipid Protects Preterm Neonates against Perinatal Nutrition–Associated Cholestasis

American Journal of Perinatology (2019)

Yair Kasirer Alona Bin‐Nun Ateret Raveh Irina Schorrs Francis B. Mimouni

Objective Intravenous lipid infusions improve both short- and long-term outcomes of premature neonates. However, prolonged infusion of lipids has been implicated in the development of parenteral nutrition-associated cholestasis (PNAC). We speculated that the multicomponent SMOFlipid would be hepatoprotective against PNAC. Study Design This is a retrospective review comparing the incidence and severity of direct hyperbilirubinemia in preterm infants <1,500 g who were hospitalized for a minimum of 2 weeks during a 20-month period in which all preterm infants on total parenteral nutrition (TPN) received fat as Lipofundin with the following 20-month period in which all preterm infants on TPN received SMOFlipid. Results Infants in the SMOFlipid period had a lower incidence of PNAC (6 vs. 13%; p = 0.022), lower peak direct bilirubin levels (3.2 vs. 7.1 mg/dL; p = 0.018), and a shorter length of stay (51 vs. 60 days; p = 0.019). The relative risk of developing direct hyperbilirubinemia during the Lipofundin period was 2.22 (1.1–4.3) as compared with period 1; p = 0.018; NNT-14. Conclusion SMOFlipid was hepatoprotective in our population of preterm neonates <1,500 g receiving long-term TPN as compared with those receiving Lipofundin, despite similar levels of exposure to both intravenous lipid load and duration in the two groups.

10.1055/s-0038-1676977

Cite

Citations (21)